Journal of Medicinal Chemistry · 2011 · 62 citations · 23 references
MedicineMedicinal ChemistryPharmacologyDrug DiscoveryNeuropharmacologyStructure-activity RelationshipsCannabinoid PharmacologyDrug-receptor InteractionsLigand BindingPotency OptimizationReceptor PharmacologyStructure-activity Relationship AnalysisAgonist ActivityCannabinoid Receptor ModulationCannabinoid Receptor PharmacologyCannabinoid Structure-activity RelationshipsInverse Agonist InteractionsMedicinal HeterocyclesSelectivity RelationshipsStructure-selectivity Relationships
Experimental evidence suggests that selective CB2 receptor modulators may provide access to antihyperalgesic agents devoid of psychotropic effects. Taking advantage of previous findings on structure-activity/selectivity relationships for a class of 4-quinolone-3-carboxamides, further structural modifications of the heterocyclic scaffold were explored, leading to the discovery of the 8-methoxy derivative 4a endowed with the highest affinity and selectivity ever reported for a CB2 ligand. The compound, evaluated in vivo in the formalin test, behaved as an inverse agonist by reducing at a dose of 6 mg/kg the second phase of the formalin-induced nocifensive response in mice.
23
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Murielle Rinaldi‐Carmona, Francis Barth, Michel Héaulme et al. · FEBS Letters · 1994 · 1.8K citations · Full text
Medicine, Neuroscience, Pharmacology +14